Cardio-ankle Velocity Index (CAVI) as a Marker of Multivessel Coronary Artery Disease in Diabetic Patient
DOI:
https://doi.org/10.61841/7kax4r34Keywords:
CAVI, Multivessel, Coronary Artery Disease.Abstract
Aim: To investigate the ability of the arterial stiffness parameter cardio-ankle velocity index (CAVI) to predict coronary disease in diabetic patient.
Method: 155 consecutive patients underwent CAVI prior for coronary angiography for different indications between March 2018 until March 2019 at Al Hussein teaching hospital-Samawah city-Iraq. Patients with atrial fibrillation, aortic valve regurgitation and low Ankle Brachial Index (ABI<0.9) were excluded. After coronary angiography, patients were categorized as those with no vessel disease (group 1), those with single vessel disease (1VD) (group 2), those with two vessels disease (2VDs) (group 3) and those with three vessels disease (3VDs) (group4). In relation to diabetes they were categorized into four groups: Those has no DM and No demonstrable CAD (Non DM. Non CAD) (group 1), those with no DM but CAD (Non DM. CAD) (group2), Those with DM and no CAD (DM. NonCAD) (group 3) and those DM and CAD (DM.CAD) (group 4).
Results: CAVI was significantly higher in those with 1VD than normal (mean±SD) (9.35±1.05 Vs 8.138±6.73) (P<0.05), Those with 2VD has significantly higher CAVI than those with no vessel disease (mean±SD) (9.8±0.84 Vs 8.13±6.73) (P<0.05), Those with 3VD has significantly higher CAVI than those with No vessel disease (mean±SD) (11.48±1.1 Vs 8.138±6.73), (P<0.001) Those with 3VDS has significantly higher CAVI than those with 2VD (mean±SD) (11.48±1.1 Vs 9.8±0.84) (P<0.05). As for Diabetics, Those with DM and CAD (group 4) has the highest CAVI among other groups (mean±SD) (10.73 ±1.323 Vs 9.865±1.346) (p<0.05).
Conclusion: CAVI can be a simple non-invasive test to predict multivessel disease in diabetic patients.
Downloads
References
[1] O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values Am J Hypertens. 2002 May; 15(5): 426-44.
[2] Nyeer: The effect of blood pressure alternation on pulse wave velocity. Br Heart J. 1964 Mar;26:261-5
[3] Shirai K1, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006 Apr; 13(2):101-7.
[4] Kawasaki, S. Sasayama, and S.I. Yagi, “Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries,” Cardiovascular search, vol. 21, no. 9, pp. 678–687, 1987.
[5] J.C. Bramwell and A. V. Hill, “Velocity of the pulse wave in man," Proceedings of the Royal Society of London, pp. 298–306, 1922.
[6] K. Sakane, T. Miyoshi, M. Doi et al., “Association of new arterial stiffness parameter, the cardio-ankle vascular index, with left ventricular diastolic function,” Journal of Atherosclerosis and Thrombosis, vol. 15, no. 5, pp. 261–268, 2008.
[7] K. Nakamura, T. Tomaru, S. Yamamura, Y. Miyashita, K. Shirai, and H. Noike, “Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis,” Circulation Journal, vol. 72, no. 4, pp. 598– 604, 2008.
[8] A. Ichihara, N. Yamashita, T. Takemitsu et al., “Cardio-Ankle Vascular Index and Ankle Pulse Wave Velocity as a Marker of Arterial Fibrosis in Kidney Failure Treated by Hemodialysis,” American Journal of Kidney Diseases, vol. 52, no. 5, pp. 947– 955, 2008.
[9] T. Okura, S. Watanabe, M. Kurata et al., “Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension,” Hypertension Research, vol. 30, no. 4, pp. 335–340, 2007.
[10] Takaki A, Ogawa H, Wakeyama T, et al. Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ J 2007; 71(11): 1710-17
[11] Saoh-Asahara N, Suganami T, Majima T, et al. and the Japan Obesity and Metabolic Syndrome Study (JOMS) Group Urinary Cystatin C as a Potential Risk Marker for Cardiovascular Disease and Chronic Kidney Disease in Patients with Obesity and Metabolic Syndrome. Clin J Am Soc Nephrol 2011; 6: 265- 273.
[12] Horinaka S; Yabe A; Yagi H; Ishimura K; Hara H; Iemua T; Matsuoka H. Comparison of atherosclerotic indicators between cardio ankle vascular index and brachial ankle pulse wave velocity. Angiology. 2009; 60(4): 468-76 (ISSN: 1940-1574).
[13] Miyoshi T, Doi M, Hirohata S Cardio-ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease. J Atheroscler Thromb. 2010 Mar 31; 17(3): 249-58.
[14] Park JB, Park HE, Choi SY Relation between cardio-ankle vascular index and coronary artery calcification or stenosis in asymptomatic subjects. J Atheroscler Thromb. 2013; 20(6): 557-67.
[15] N.J. Morrish, S.L. Wang, L.K. Stevens et al., “Mortality and causes of death in the WHO multinational study of vascular disease in diabetes,” Diabetologia, vol. 44, no. 2, pp. S14–S21, 2001.
[16] L. De Angelis, S.C. Millasseau, A. Smith et al. “Sex differences in age-related stiffening of the aorta in subjects with type 2 diabetes,” Hypertension, vol.44,no.1,pp.67–71,2004
[17] E. Kimoto, T. Shoji, K. Shinohara et al. “Preferential stiffening of central over peripheral arteries in type 2 diabetes,” Diabetes, vol.52, no.2, pp. 448–452, 2003.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
